Binding domains from Plasmodium vivax and Plasmodium falciparum erythrocyte binding proteins
US5849306A · kind A · utility
11Cited by
1References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 7, 1995 |
| Grant date | Dec 15, 1998 |
| Priority date | — |
| Expiry date | Dec 7, 2015 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides isolated polypeptides useful in the treatment and prevention of malaria caused by Plasmodium falciparum or P. vivax. In particular, the polypeptides are derived from the binding domains of the proteins in the EBL family as well as the sialic acid binding protein (SABP) on P. falciparum merozoites. The polypeptides may also be derived from the Duffy antigen binding protein (DABP) on P. vivax merozoites.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.